This compound is primarily utilized in the pharmaceutical industry as a chiral building block for the synthesis of active pharmaceutical ingredients (APIs). Its structure, featuring a trifluoromethyl group and a fluorophenyl moiety, makes it valuable in the development of drugs targeting central nervous system (CNS) disorders, such as antidepressants and antipsychotics. The presence of fluorine atoms enhances the molecule's stability, bioavailability, and binding affinity to biological targets. Additionally, it is employed in the production of enantiomerically pure compounds, which are critical for ensuring the efficacy and safety of chiral drugs. Its application extends to research and development in medicinal chemistry, where it serves as a key intermediate in the design of novel therapeutic agents.